These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1654911)

  • 1. [Practical approach to the discovery of a positive HCV serology in a blood donor].
    Elghouzzi MH; Giral P; Opolon P; Trepo C; Poupon R; Jullien AM
    Rev Fr Transfus Hemobiol; 1991 Jul; 34(4):315-42. PubMed ID: 1654911
    [No Abstract]   [Full Text] [Related]  

  • 2. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 5. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 8. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U].
    Lunel F; Azar N; Fournel JJ; Valla D; Foucault C; Habibi B; Jaulmes D; Perrin M; Opolon P; Huraux JM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):361-7. PubMed ID: 2177600
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Vernelen K; Claeys H; Verhaert H; Volckaerts A; Vermylen C
    Lancet; 1994 Apr; 343(8901):853. PubMed ID: 7511194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hepatitis C in a population of hemodialysis patients.
    Mosconi G; Campieri C; Miniero R; Colì L; Orsi C; La Manna G; De Sanctis LB; Stefoni S; Sprovieri G; Bonomini V
    Nephron; 1992; 61(3):298-9. PubMed ID: 1323773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
    Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C].
    Lissen E; Pineda JA
    Enferm Infecc Microbiol Clin; 1991; 9(6):320-2. PubMed ID: 1657206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.